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A facile and one step-method was developed to enhance the 
water stability of CD-MOF nanoparticles through surface 
modification with cholesterol. CD-MOFs were able to maintain 
their cubic crystalline structures even after 24 hrs incubation, well 
tolerated in vivo and could increase up to 4 times the blood half-
life of DOX. 
Metal organic frameworks (MOFs) are a versatile class of 
porous and crystalline material with potential applications in 
gas storage and separation, catalysis, sensors and drug 
delivery.
1-5
 The MOFs gained increased attention in recent 
years due to their chemical versatility and tunable porosity, 
but unfortunately, the practical applications are hampered in 
many cases by their moisture-sensitive nature
6
. For instance, 
γ-cyclodextrin based MOFs (γ-CD-MOFs) are a class of almost 
perfectly shaped, crystalline and porous materials build by 
coordination of γ-CDs and potassium (K) ions
7,8
. The γ-CD-
MOFs have become very popular in reason of their 
biocompatibility and prospective applications in gas storage 
and biomedicine
9,10
. However, these applications face serious 
challenges related to the poor stability of γ-CD-MOFs which 
rapidly disintegrate when exposed to the humid conditions. 
Nevertheless, only three strategies have been reported so far 
to improve the stability of γ-CD-MOFs in water. Furukawa et al. 
used ethylene glycol diglycidyl ether to crosslink γ-CD-MOFs to 
produce γ-CD-MOF hydrogels
11
. However, the synthesis was 
time-consuming, taking more than three days at 65 °C and 
several steps were required to remove the unreacted 
crosslinker. Recently, Li et al. incorporated fullerene (C60) in 
the γ-CD-MOF the matrices in an attempt to increase their 
aqueous stability
12
. However, the supramolecular assemblies 
did not maintain their structure over prolonged times and 
eventually degraded in water after 24h incubation due to the 
weak interaction between C60 γ-CDs and in CD-MOFs. 
Moreover, the occupancy of γ-CD cavities by C60 might also 
reduce the capacity of γ-CD-MOFs to load drugs. Very recently, 
we successfully cross-linked the γ-CD using diphenyl carbonate 
to get water insoluble cubes
13
. However, the crystalline 
structure was lost after cross-linking and 8 hrs Soxhlet 
extraction was required to remove the byproduct phenol. 
Thus, there is still an urgent need to develop CD-MOFs with 
good stabilities in aqueous environments, without affecting 
their porous and crystalline structure nor their ability to 
incorporate drugs. The elaboration of such water-“shielded” 
CD-MOFs would pave the way towards their applications in 
drug delivery and other fields.  
 
 
 
 
Figure 1.Schematic illustration of CD-MOF surface modification 
by cholesterol (CHS). 
 
Herein, we developed a straightforward one-step and effective 
strategy to graft cholesterol (CHS) to form a protective 
hydrophobic layer over the surface of CD-MOF in order to 
enhance their aqueous stability (Fig. 1). CHS is one of the most 
common endogenous physiological molecules that has been 
tremendously used in self-assembly, nanoparticle modification 
and hydrophobicity enhancement of various systems
14-16
. 
According to recent studies, nanoparticles made from 
biocompatible polymers and coated with CHS were shown to 
effectively deliver anti-cancer drugs, nucleic acids used in gene 
therapy, and imaging agents inside cells, irrespective of the 
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shape of the carriers
17, 18
. The CHS shielded CD-MOF (CD-MOF-
CHS) developed here turned out to be hydrophobic showing a 
significant enhancement in water stability and maintained an 
intact outer and inner crystalline structure.  
Nanosized CD-MOFs (~200nm) were synthesized according to 
our recently published procedure
19
. An optimized simple 
chemical reaction was set up for the surface modification of 
CD-MOF with CHS using a coupling agent and a catalyst, at 45 
°C in DMF for 24 h. The samples were chemically characterized 
by FTIR and Raman spectroscopies showing a successful 
linkage of CHS to the hydroxyl groups of γ-CDs in CD-MOFs. For 
instance, the presence of a carbonyl peak at 1720 cm
-1 
confirmed the conjugated ester linkage in CD-MOF-CHS 
samples (Figure S-1). As shown in Figure 1A, the specific peak 
of ester carbonyl in Raman spectra (C=O) at 1668 cm
-1
 can be 
clearly observed in CD-MOF-CHS, whilst no such signal was 
obtained in CD-MOF. This again confirmed the successful 
grafting of CHS to the CD-MOF. The thermal stability of CHS-
modified nanoparticles was studied and compared with that of 
CD-MOF using thermogravimetric analysis and differential 
scanning calorimetry (Figures S-2 and S-3). It was concluded 
from these studies that the CD-MOFs contained around 7 wt% 
grafted γ-CD+CHS. 
 
 
 
Figure 2.Physicochemical characterizations. Raman spectra of 
CHS, CD-MOF and CD-MOF-CHS for structural confirmation (A). 
Digital photographs of CD-MOF and CD-MOF-CHS after placing 
a drop of water on the nanoparticle powders. Inserts show the 
water contact angle measurement for the respective samples 
(B). 
 
The amount of CHS grafted to the CD-MOFs was quantified by 
high performance liquid chromatography (HPLC). To do so, the 
CD-CHS covalent bonds were hydrolyzed with ammonia 
leading to particle disintegration and CHS release. The CHS 
amount in the CD-MOF-CHS was 3.21 (wt%) which is total 
agreement of TGA results showing combined 7 (wt%) of γ-CD 
and CHS (almost doubled due to γ-CD contribution). Supposing 
that CHS was grafted only to the CDs at the surface of the CD-
MOFs, mathematical calculations provided in the supporting 
information showed that each CD would bear around 5.8 
grafted CHS molecules. 
Scanning electron microscopy-Energy-dispersive X-ray 
spectroscopy (EDS) based elemental analysis was used to 
quantitatively determine the CHS content in the CD-MOF top 
layers20. The obtained results (TableS-1) showed a sharp 
decrease in potassium content, from 9.07% (CD-MOF) to 
3.39% (CD-MOF-CHS)particles. These findings, together with 
the increase in carbon and oxygencontents in the CD-MOF-CHS 
as compared to the CD-MOF (see SI) clearly indicate the 
presence of CHS in the top layers of CD-MOF-CHS. 
 
 
 
Figure 3.SEM images of CD-MOF (A), CD-MOF-CHS (B), CD-
MOF-CHS immersed in water for 12 hrs (C) and 24 hrs (D) in 
comparison. 
The efficacy of the CHS coating on the particle stability in 
aqueous media was investigated. The instability of CD-MOFs in 
water is well known. As soon as a water droplet is put on top 
of a CD-MOF powder, it starts dissolving the particles (Fig. 2B). 
As a consequence, in water contact angle measurements, the 
CD-MOF possessed zero water contact angle due to the 
hydrophilic nature of this material. On the opposite, a drop of 
water deposited on the top of a CD-MOF-CHS powder adopted 
a round shape and was not aspired by the powder. A contact 
angle of 120±1 was recorded, revealing the hydrophobic 
character of the CD-MOF-CHS (Fig. 2B). Furthermore, the 
stability in water of the CD-MOF-CHS was tested by immersing 
the particles in water for 12 and 24 h, respectively. Remarkably 
it was found that the particles maintained their integrity (Fig. 
3), whereas the CD-MOFs control samples immediately 
disintegrated. 
 
 
 
Figure 4.PXRD characterization of CD-MOF and CD-MOF-CHS 
before and after water treatment for 12 hrs and 24 hrs (C). 
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The CHS-modified CD-MOFs have similar morphologies and 
size distributions as their parent CD-MOFs (Fig. 3 A and B), 
showing that the grafting reaction did not affect their 
supramolecular structures. After 12 h and 24 h incubation in 
water the samples retained their cubic shapes, but the edges 
became rounder (Fig. 3 C and D). These morphological changes 
could be attributed to water penetration inside the network, 
leading to progressive degradation. It was therefore 
interesting to study if CD-MOF-CHS maintained their crystalline 
structures in water. 
Firstly, X-Ray powder diffraction studies (Fig 4) confirmed that 
the crystalline structure of the CD-MOFs was intact after their 
modification with CHS (Fig 4). It is worth mentioning that the 
other surface modification methods reported so far, such as 
C60-protection and cross-linking, lead to an almost total loss of 
crystallinity
11
. In contrast, even after 12 h incubation in water, 
the CD-MOF-CHS maintained their crystalline structure (Fig 4). 
In a nutshell, these data clearly show the potential of CHS 
grafting to preserve the supramolecular structure of the CD-
MOF in aqueous media over long enough periods of time to 
envisage biomedical applications.  
 
 
 
 
Figure 5.(A) Nitrogen adsorption isotherms for CD-MOF, CD-
MOF-CHS and CD-MOF-CHS immersed in water for 12 h and 24 
h (B).Time dependent DOX incorporation into CD-MOF-CHS in 
water. Insert show the linear fit of data using a pseudo-second 
order kinetic model. 
 
To explain the dramatically increased stability of CHS shielded 
CD-MOFs in water, simulations were carried on using 
molecular dynamics to calculate the water solvation energy in 
CD-MOFs and CD-MOF-CHS samples.The water solvation 
energy of single CD and single CD grafted with 6 cholesterol 
molecules were 90.7 kcal/mol and 30.8 kcal/mol, respectively 
(Figure S-4). The one third decreases in solvation energy after 
CHSgrafting could be one of the main reason of the 
observedenhanced stability of CD-MOF-CHS particles in water. 
The effect of CHS grafting upon the specific surface areas was 
studied before and after incubation in water (Fig 5). As 
expected, the surface areas were dramatically reduced upon 
CHS grafting. Possibly, a dense CHS layer at the particles’ 
surface interfered with N2 adsorption, leading to an almost 
50% reduction of the BET surface areas from 455.1 m2/g to 
203.9 m2/g. Of note, the porosity of the CD-MOF-CHS was 
practically unchanged after immersion in water for 12 h, 
indicating that degradation was not significant. These data are 
in agreement with X-Ray diffraction studies (Fig 4) showing a 
good integrity of the crystalline structures after incubation in 
water for 12 h. However, further reduction in surface area of 
24 h sample was noticed due to progressive degradation as 
suggested by SEM images. 
In conclusion, the CHS-shielded CD-MOF possessed high 
stability, mesoporous structure, and biofriendly frameworks 
made of γ-CDs and CHS. These characteristics make CD-MOF-
CHS particularly appealing as drug carriers. Herein, we 
investigated their ability to incorporate DOX, one of the most 
widely used anticancer drug (see molecular structure in Figure 
S-5). The CD-MOF-CHS were able to load DOX simply by 
soaking from aqueous solutions, reaching drug adsorption 
capacities of 60-80 mg/g (Figure 5B). The DOX absorption was 
fitted very well with a pseudo-second order kinetic model. The 
obtained R2 value (0.99) suggested that the rate controlling 
step of adsorptions was mainly the interaction between 
negatively charged pores and DOX in neutral 
medium.Moreover, the CD-MOF-CHS particles were able to 
maintain their crystalline structure after DOX loading as shown 
in Figure S-6. DOX loaded CD-MOF-CHS showed the feature 
shift of DOX in 
1
HNMR analysis (Figure S-7) which is in 
complete agreement with previously published study to 
confirm the DOX presence inside the framework cavities
12
. 
Additionally, elemental analysis was carried out on DOX loaded 
CD-MOF-CHS cubes using high resolution SEM-EDS device and 
the presence of nitrogen (attributed to the DOX structure) in 
high proportion again confirmed the DOX loading (Table S-2).  
It is well documented that CHS grafting or modification of 
DOX-loaded nanoparticles enhances the cellular penetration of 
DOX
20
. Similar experiments were carried on here to investigate 
if the cellular penetration of DOX incorporated in CD-MOF-CHS 
particles was higher than that of the free drug. HeLa 
cellsstained with DAPI to locate their nuclei were incubated for 
4 h with free DOX or DOX-loaded CD-MOF-CHS nanoparticles. 
Confocal microscopy images showed a higher intensity of DOX 
signal inside the cells and deposition on cell membranes in the 
case of DOX-loaded CD-MOF-CHS nanoparticles as compared 
with free DOX (Fig.6). Possibly, the CHS shell played a role in 
promoting cell internalization of the drug as reported 
previously
21
. 
 
Figure 6.Confocal images of HeLa cells showing cellular uptake 
of DOX loaded in CD-MOF-CHS at 4 hrs incubation and free 
DOX in comparison. The nuclei were stained with DAPI 
(middle). The image was representative of three experiments 
with similar results. 
The CD-MOF-CHS nanoparticles were nontoxic in vitro up to 
concentrations of 100 µg/mL as determined by MTT assays 
(Figure S-8). This encouraged us to test them in vivo. Doses of 
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5mg/kg of empty CD-MOF-CHS NPs administered by 
intravenous injection in rats were well tolerated. Finally, DOX-
loaded CD-MOF-CHS were administered and their blood 
clearance was evaluated and compared with free DOX through 
a pharmacokinetic study. 
 
Figure 7.Concentration-time profiles of DOX in plasma of male 
Sprague–Dawley rats after a single intravenous administration 
of free DOX and CD-MOF-CHS loaded with DOX (equivalent to 
5mg/kg DOX). Experiments were conducted with groups of 8  
rats. 
 
As shown in Figure 7, free DOX was rapidly cleared from blood 
circulation in comparison with the same doses of DOX 
incorporated in CD-MOF-CHS. This clearly indicates a decrease 
of DOX clearance from blood. More precisely, the blood 
circulation half-lives (t1/2) of DOX in CD-MOF-CHS were 4 
times higher than for free DOX. Moreover, CD-MOF-CHS 
exhibited significantly increased area under the curve (AUC) in 
blood, that is, 1.55 times higher than free DOX. All other 
pharmacokinetic parameters were listed in supplementary 
table S-3. Possibly the CD-MOF-CHS, stabilized against 
dissolution in water, allowed a more sustained release of DOX. 
Further studies will be needed to gain insights on the in vivo 
fate of CD-MOF-CHS. 
In summary, a facile method for the protection of CD-MOF 
from quick hydration in water via CHS shielding was reported. 
The coated solids became hydrophobic and were able to retain 
their porosity, intact morphology and crystallinity even after 
24 h of water treatment. The presented methodology to 
enhance the water stability of CD-MOFs appears more efficient 
than the previously reported strategy of CD-MOF protection by 
C60 incorporation. Incorporated DOX was better internalized 
in cells and in vivo studies showed improved pharmacokinetics 
of the drug in CD-MOF-CHS as compared to its free form. With 
further studies, the engineered CD-MOF-CHS nanoparticles, 
endowed with a biofriendly framework and high drug 
absorption capacity might find potential applications for drug 
delivery. 
 
This work was supported by the National Natural Science 
Foundation of China (81430087). 
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